CAS 83913-06-8
:rel-3,4-Dicloro-N-metil-N-[(1R,2R)-2-(1-pirrolidinil)ciclohexil]benzacetamida metanosulfonato (1:1)
- Benzeneacetamide, 3,4-dichloro-N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]-, rel-, monomethanesulfonate
- rel-3,4-Dichloro-N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide methanesulfonate (1:1)
- Benzeneacetamide, 3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-, trans-(±)-, monomethanesulfonate
- Benzeneacetamide, 3,4-dichloro-N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]-, rel-, methanesulfonate (1:1)
- U 50488H
(+)-trans-U 50488H methanesulfonate
CAS:Producto controlado(+)-trans-U 50488H methanesulfonate is a non-peptide compound that binds to the kappa-opioid receptor. It has been shown to be an agonist of the corticotropin-releasing hormone and adrenocorticotropic hormone receptors in vitro, with approximately 10% of the potency of arginine vasopressin. (+)-trans-U 50488H methanesulfonate is a potent antihypertensive agent that has been shown to be effective in animal models. The drug also has a vasoconstrictive effect, which may be due to its ability to increase blood pressure by constricting smooth muscle cells in blood vessels. This drug also decreases the release of ACTH and cortisol from the anterior pituitary gland, which may be related to its ability to antagonize corticotropin-releasing hormone and adrenocorticotropic hormone receptors.
Fórmula:C20H30Cl2N2O4SPureza:Min. 95%Peso molecular:465.4 g/mol
